Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics. FDA Individual Bioequivalence Working Group.
Patnaik
R N
RN
Division of Bioequivalence, Food and Drug Administration, Rockville, Maryland, USA.
Lesko
L J
LJ
Chen
M L
ML
Williams
R L
RL
D019540:Area Under Curve; D001682:Biological Availability; D008954:Models, Biological; D010599:Pharmacokinetics; D013810:Therapeutic Equivalency